JAMA. 2022 Jan 20:e220210. doi: 10.1001/jama.2022.0210. Online ahead of print.
ABSTRACT
This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.
PMID:35050314 | PMC:PMC8778597 | DOI:10.1001/jama.2022.0210